Maynard Um
-
-
-
-
-
-
-
Trevi Therapeutics (TRVI) PT Lowered to $24 at Jones Trading
-
-
-
-
-
-
-
Trevi Therapeutics schedules FDA meeting for chronic cough drug program
-
-
-
-
-
-
-
Trevi Therapeutics (TRVI) Tops Q3 EPS by 2c
-
-
-
-
-
-
-
Stifel Reiterates Buy Rating on Trevi Therapeutics (TRVI)
-
-
-
-
-
-
-
Stifel Reiterates Buy Rating on Trevi Therapeutics (TRVI)
-
-
-
-
-
-
-
Stifel Reiterates Buy Rating on Trevi Therapeutics (TRVI)
-
-
-
-
-
-
-
Raymond James Upgrades Trevi Therapeutics (TRVI) to Strong Buy, PT $29
-
423,233 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

